公开(公告)号：US09597227B2

公开(公告)日：2017-03-21

申请号：US13837892

申请日：2013-03-15

Applicant: Abbott Medical Optics Inc.

Inventor： Daniel J. Urbaniak ,  John J. Stankus ,  James Su

IPC: A61F9/00 ,  A61F9/007 ,  A61M39/02 ,  A61K9/00

CPC classification number: A61F9/0017 ,  A61F9/0008 ,  A61F2210/0061 ,  A61F2250/0067 ,  A61F2250/0068 ,  A61K9/0004 ,  A61K9/0048 ,  A61K9/0051 ,  A61K9/06 ,  A61K31/337 ,  A61K31/4168 ,  A61K31/498 ,  A61K31/5377 ,  A61K31/5575 ,  A61K31/573 ,  A61K35/28 ,  A61K39/3955 ,  A61K47/32 ,  A61K47/34 ,  A61M2039/0276 ,  A61M2210/0612 ,  G02B1/043

Abstract: A portal through the sclera for delivery of an effective amount of therapeutic agent to the back of the eye.

公开(公告)号：US10111776B2

公开(公告)日：2018-10-30

申请号：US14971664

申请日：2015-12-16

Applicant: ABBOTT MEDICAL OPTICS INC.

Inventor： Brooke C. Basinger ,  Daniel J. Urbaniak

IPC: A61F9/00 ,  A61K9/00

Abstract: The present invention relates to an apparatus, system and method for, and for providing, intraocular delivery of an active agent. The apparatus, system and method may include an implantable scaffold and an active agent associated with the implantable scaffold. The implantable scaffold and the active agent may be configured to be completely contained within the eye upon implantation. The implantable scaffold may be a mechanical scaffold, or the implantable scaffold may be a chemical scaffold.

公开(公告)号：US20140276329A1

公开(公告)日：2014-09-18

申请号：US13837892

申请日：2013-03-15

Applicant: ABBOTT MEDICAL OPTICS INC.

Inventor： Daniel J. Urbaniak ,  John J. Stankus ,  Syed Hossainy ,  James Su ,  Mikael Trollsas

IPC: A61F9/00 ,  A61F9/007

CPC classification number: A61F9/0017 ,  A61F9/0008 ,  A61F2210/0061 ,  A61F2250/0067 ,  A61F2250/0068 ,  A61K9/0004 ,  A61K9/0048 ,  A61K9/0051 ,  A61K9/06 ,  A61K31/337 ,  A61K31/4168 ,  A61K31/498 ,  A61K31/5377 ,  A61K31/5575 ,  A61K31/573 ,  A61K35/28 ,  A61K39/3955 ,  A61K47/32 ,  A61K47/34 ,  A61M2039/0276 ,  A61M2210/0612 ,  G02B1/043

Abstract: A portal through the sclera for delivery of an effective amount of therapeutic agent to the back of the eye.

Abstract translation: 通过巩膜的入口，用于将有效量的治疗剂递送至眼睛后部。

公开(公告)号：US20160106585A1

公开(公告)日：2016-04-21

申请号：US14971664

申请日：2015-12-16

Applicant: ABBOTT MEDICAL OPTICS INC.

Inventor： Brooke C. Basinger ,  Daniel J. Urbaniak

IPC: A61F9/00

CPC classification number: A61F9/0017 ,  A61K9/0051

Abstract: The present invention relates to an apparatus, system and method for, and for providing, intraocular delivery of an active agent. The apparatus, system and method may include an implantable scaffold and an active agent associated with the implantable scaffold. The implantable scaffold and the active agent may be configured to be completely contained within the eye upon implantation. The implantable scaffold may be a mechanical scaffold, or the implantable scaffold may be a chemical scaffold.